HRT Financial’s BioNTech BNTX Stock Holding History

HRT Financial’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,200	Closed	-$1.86M	–	3127
2021 Q4	$1.86M	Buy	7,200 +2,400	+50%	+$657K	0.01%	705
2021 Q3	$1.31M	Buy	4,800 +2,400	+100%	+$763K	0.01%	1046
2021 Q2	$537K	Buy	+2,400	New	+$453K	﹤0.01%	1700

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's BNTX Position: Q1 2026 in Review

HRT Financial sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 7,213 shares — an estimated $686K sold.

HRT Financial first reported a position in BNTX in Q2 2022 and held it in 6 quarters. The position peaked at $3.64M in Q3 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

HRT Financial reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 7,213 BioNTech shares in Q1 2026, an estimated $686K.
HRT Financial first reported a position in BioNTech in Q2 2022 and held it in 6 quarters.
HRT Financial's BioNTech position peaked at $3.64M in Q3 2025.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.